Company: NKLR
Filing Date: 2025-12-16
Form Type: 424B3
Source: 0001213900-25-121900
Chunk: 52

Company: Terra Innovatum Global N.V.
Filing Date: 2025-12-16
Form: 424B3
Chunk 52
---
 we may become involved in various
legal proceedings relating to matters incidental to the ordinary course of our business, including intellectual property, commercial,
product liability, employment, class action, whistleblower and other litigation and claims, and governmental and other regulatory investigations
and proceedings. Such matters can be time-consuming, divert management’s attention and resources from the operation of our business
and cause us to incur significant expenses or liability or require us to change our business practices. Because of the potential risks,
expenses and uncertainties of litigation, from time to time, we may settle disputes, even where we believe that we have meritorious claims
or defenses. Because litigation is inherently unpredictable, we cannot assure you that the results of any of these actions will not have
a material adverse effect on our business.

<div align='center'>22</div>

Terra Innovatum’s failure to timely and effectively implement controls and procedures required by Section 404(a) of the Sarbanes-Oxley Act that will be applicable to it after the Business Combination is consummated could negatively impact its business.

Prior to the consummation of the Business Combination,
Terra Innovatum was not subject to Section 404 of the Sarbanes-Oxley Act. However, as a result of the consummation of the Business
Combination, Terra Innovatum is required to provide management’s attestation on internal controls. The standards required for a
public company under Section 404(a) of the Sarbanes-Oxley Act are significantly more stringent than those required of Terra
Innovatum as a privately held company. Management may not be able to effectively and timely implement controls and procedures that adequately
respond to the increased regulatory compliance and reporting requirements that will be applicable after the Business Combination. If
Terra Innovatum management is unable to conclude that we have effective internal control over financial reporting, or to certify the
effectiveness of such controls, and ourindependent registered public accounting firm cannot render an unqualified opinion
on management’s assessment and the effectiveness of our internal control over financial reporting at such time as it is required
to do so, and material weaknesses in our internal control over financial reporting are identified, we could be subject to regulatory
scrutiny, a loss of public and investor confidence, and to litigation from investors and shareholders, which could have a material adverse
effect on our business and our stock price. In addition, if we do not maintain adequate financial and management personnel, processes
and controls, we may not be able to manage our